Literature DB >> 11420185

Alpha-1 antitrypsin deficiency.

R A Primhak1, M S Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11420185      PMCID： PMC1718832          DOI： 10.1136/adc.85.1.2

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  49 in total

1.  Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency.

Authors:  P Mazodier; A N Elzouki; M Segelmark; S Eriksson
Journal:  QJM       Date:  1996-08

2.  alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation.

Authors:  K O'Riordan; A Blei; M S Rao; M Abecassis
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

3.  Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K.

Authors:  M Cornelissen; R von Kries; P Loughnan; G Schubiger
Journal:  Eur J Pediatr       Date:  1997-02       Impact factor: 3.183

4.  Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation.

Authors:  A N Elzouki; S Lindgren; S Nilsson; B Veress; S Eriksson
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

5.  Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

Authors:  N Seersholm; M Wencker; N Banik; K Viskum; A Dirksen; A Kok-Jensen; N Konietzko
Journal:  Eur Respir J       Date:  1997-10       Impact factor: 16.671

6.  An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover.

Authors:  R Hirschhorn; D R Yang; A Israni
Journal:  Ann Hum Genet       Date:  1994-01       Impact factor: 1.670

7.  Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy.

Authors:  R von Kries; U Göbel
Journal:  Acta Paediatr       Date:  1992-09       Impact factor: 2.299

8.  Lung function in adolescents with alpha 1-antitrypsin deficiency.

Authors:  T Sveger; E Piitulainen; M Arborelius
Journal:  Acta Paediatr       Date:  1994-11       Impact factor: 2.299

9.  Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency.

Authors:  N Novoradovskaya; J Lee; Z X Yu; V J Ferrans; M Brantly
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

10.  The liver in adolescents with alpha 1-antitrypsin deficiency.

Authors:  T Sveger; S Eriksson
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425
View more
  8 in total

1.  Activity of the yeast Tat2p tryptophan permease is sensitive to the anti-tumor agent 4-phenylbutyrate.

Authors:  Ming Liu; William S A Brusilow; Richard Needleman
Journal:  Curr Genet       Date:  2004-11       Impact factor: 3.886

2.  Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.

Authors:  Steven J Steiner; Sandeep K Gupta; Joseph M Croffie; Joseph F Fitzgerald
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

Review 3.  Managing liver failure.

Authors:  D A Kelly
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

4.  Early-onset, Severe Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension that was Likely Induced by Toluene Exposure.

Authors:  Konomi Kobayashi; Manabu Suzuki; Shota Yamamoto; Keisuke Ueno; Eriko Miyawaki; Ikuo Takazawa; Ayako Shiozawa; Teruhiko Sato; Masayuki Hojo; Haruhito Sugiyama
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

5.  Biological Treatments and Target Therapies for Pediatric Respiratory Medicine: Not Only Asthma.

Authors:  Sergio Ghirardo; Michele Mazzolai; Antonio Di Marco; Francesca Petreschi; Nicola Ullmann; Marta Lucia Ciofi Degli Atti; Renato Cutrera
Journal:  Front Pediatr       Date:  2022-02-15       Impact factor: 3.418

6.  An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression.

Authors:  Meredith Corley; Amanda Solem; Gabriela Phillips; Lela Lackey; Benjamin Ziehr; Heather A Vincent; Anthony M Mustoe; Silvia B V Ramos; Kevin M Weeks; Nathaniel J Moorman; Alain Laederach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

Review 7.  The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Authors:  Yu-Ching Su; Farshid Jalalvand; John Thegerström; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

Review 8.  Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

Authors:  María Torres-Durán; José Luis Lopez-Campos; Miriam Barrecheguren; Marc Miravitlles; Beatriz Martinez-Delgado; Silvia Castillo; Amparo Escribano; Adolfo Baloira; María Mercedes Navarro-Garcia; Daniel Pellicer; Lucía Bañuls; María Magallón; Francisco Casas; Francisco Dasí
Journal:  Orphanet J Rare Dis       Date:  2018-07-11       Impact factor: 4.123
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.